Avid Bioservices Inc (CDMO)

[entdoc]

dia, north40k ask if any here are aware of a "scientist" who has written about the positive outlook for Bavituximab (or Cotara). I too have often wondered why PPHM pipeline products are never mentioned in papers and presentations on the subject. I just searched PubMed database, and the only "neutral" mention of Bavi was (unfortunately) on possible new pancreatic cancer treatment strategies. That said, I do not think the absence of literature kudos at this stage is necessarily a bad thing, but it does speak to the equivocal results and small scale trials to date. Once PIII trials commence another larger wave of public and scientific scrutiny will occur, and there are not many new therapeutic agents that have had equally extensive preclinical MOA/safety studies which attest to the logic of Bavi.